Dana T. Aftab
Equibles does not estimate personal net worth.
Get an email with a short summary when Exelixis, Inc. publishes a filing, an earnings call transcript or a press release.
Get EXEL alertsAbout Dana T. Aftab
The proxy statement of Exelixis, Inc. reports total compensation of $10,547,248 for Dana T. Aftab in fiscal 2025, including a base salary of $659,058. Disclosed compensation is on record for 3 fiscal years. Exelixis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exelixis, Inc. includes Michael M. Morrissey (CEO and Board Member), Michael Morrissey (CEO and Board Member), Christopher Senner (CFO) and 7 others.
Affiliation history
-
Exelixis, Inc. (EXEL)
Proxy statement
CurrentStart not stated–present
Last confirmed April 15, 2026
Company network
Leadership on record at Exelixis, Inc.
- Michael M. Morrissey CEO, Board Member
- Michael Morrissey CEO, Board Member
- Christopher Senner CFO
- Brenda Hefti, J.D., Ph.D. General Counsel
- Brenda J. Hefti General Counsel
- Alan M. Garber, M.D., Ph.D. Board Member
- Carl B. Feldbaum, Esq. Board Member
- Charles Cohen, Ph.D. Board Member
- David E. Johnson Board Member
- George Poste Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Exelixis, Inc. (EXEL) | Executive Vice President, Research and Development | $659,058 | $10,547,248 |
| 2024 | Exelixis, Inc. (EXEL) | Executive Vice President, Discovery and Translational Research and Chief Scientific Officer | $619,316 | $3,616,578 |
| 2023 | Exelixis, Inc. (EXEL) | Executive Vice President, Discovery and Translational Research and Chief Scientific Officer | $577,920 | $5,653,142 |
Recent activity
No call appearances or filed executive changes recorded yet.